194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy
No abstract is available for this record.
Bibliographic context
- Journal
- Biological Psychiatry
- Date
- 2025-04-08
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
psilocybin DepressionRandomized Controlled TrialTreatment-Resistant Depression Randomized Controlled Trial PsilocybinPsychosocialOpen labelPsychotherapistDepression (economics)PsychologyClinical psychologyPsychiatryMedicineRandomized controlled trialHallucinogenInternal medicineMacroeconomicsEconomicsPsychedelics and Drug StudiesDigital Mental Health InterventionsChemical synthesis and alkaloids
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-03Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30